Clinical trial
A Randomized Controlled Blinded Multi-centre Study of Photodynamic Therapy With Methyl-aminolevulinate Comparing a Simplified Regime With the Approved Regime in Patients With Clinical Low-risk Superficial and Nodular Basal Cell Carcinoma.
NCT01482104 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Blinded Multi-centre Study of Photodynamic Therapy With Methyl-aminolevulinate Comparing a Simplified Regime With the Approved Regime in Patients With Clinical Low-risk Superficial and Nodular Basal Cell Carcinoma.
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2012
- Completion date
- October 31, 2017
- Enrollment
- 277 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma, basal cell, skin neoplasms